Figure 1From: Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer Gene expression changes induced by 17AAG. Averaged number of genes with expression changes >2-fold following 17AAG treatment are represented for all breast cancer cell lines, at both time points 24 H and 48 H. Resistant cell lines MDA-MB-231 and T47 D exhibited much lower variation after treatment.Back to article page